Blaž Gorjup, founder and chairman of private label company, PharmaLinea, discusses the current state of the immune health category together with Charlotte Bastiaanse:
- Strategy considerations for brands looking to accelerate an immune health product to market
- Time and risk factors considerations for product development
- Product differentiation in a competitive marketplace
- Protecting brand integrity and adjusting messaging in light of the COVID-19 crisis
- Gaps for opportunity and innovation within the immune health category when markets return to normal
If you do like the show, make sure to subscribe and follow the Vitafoods Insights podcast. Feel free also to recommend the show to a friend that you think would enjoy it.
 |
 |
 |
